UPC-logo.png
Universe Pharmaceuticals INC Enters into Letter of Intent for Strategic Cooperation with Kitanihon Pharmaceutical Co., Ltd.
25 mai 2021 08h00 HE | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, May 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the...
Universe Pharmaceuticals INC Attends West Lake Forum and Exhibits Upgraded Products
12 mai 2021 08h00 HE | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, May 12, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the Company...
UPC-logo.png
Universe Pharmaceuticals INC Announces Full Exercise of Underwriter’s Over-Allotment Option in the Public Offering
31 mars 2021 16h15 HE | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, March 31, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the...
UPC-logo.png
Universe Pharmaceuticals INC Announces Closing of Initial Public Offering
25 mars 2021 16h20 HE | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing...
UPC-logo.png
Universe Pharmaceuticals INC Announces Pricing and Trading of Initial Public Offering
23 mars 2021 08h50 HE | Universe Pharmaceuticals INC
Ji’an, Jiangxi, China, March 23, 2021 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”), a pharmaceutical producer and distributor in China, today announced the pricing of its initial...